NIFTY23,4240.08%
SENSEX74,3820.05%
BANKNIFTY54,2780.17%
NIFTY IT29,3320.18%
PHARMA24,2060.50%
AUTO26,2450.58%
FMCG48,2620.29%
METAL13,4400.71%
REALTY766.500.51%
ENERGY40,4330.59%
NIFTY23,4240.08%
SENSEX74,3820.05%
BANKNIFTY54,2780.17%
NIFTY IT29,3320.18%
PHARMA24,2060.50%
AUTO26,2450.58%
FMCG48,2620.29%
METAL13,4400.71%
REALTY766.500.51%
ENERGY40,4330.59%

Balkrishna Industries Sees Revenue Growth, Upgrades Rating to BUY

Balkrishna Industries (BKT) has reported a 6.6% year-over-year (YoY) growth in consolidated revenue to Rs. 2,933cr in Q4FY26, driven by a 5% YoY increase in sales volume to 85,820 MT. The company's revenue growth is attributed to a higher topline, which contributed to a 4.3% YoY growth in Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) to Rs. 640cr in Q4FY26.

However, BKT's EBITDA margin narrowed by 50 basis points (bps) YoY to 21.8% in Q4FY26 due to a rise in raw material expenses (+11.6% YoY) and other expenses (+18.9% YoY). As a result, the company's reported profit after tax (PAT) declined by 18.7% YoY to Rs. 299cr in Q4FY26, primarily due to an adverse movement in other income.

Financial Performance Comparison

Read also: ICICI Bank Emerges as Top Pick Among Lenders, Asset Quality Remains Resilient: Motilal Oswal

Q4FY26Q4FY25
Consolidated RevenueRs. 2,933crRs. 2,755cr
Sales Volume85,820 MT81,800 MT
EBITDARs. 640crRs. 614cr
EBITDA Margin21.8%22.8%
PATRs. 299crRs. 368cr

Looking ahead, the company plans to maintain its US volume at 10% of total sales in FY27. BKT's capital expenditure (capex) estimate for FY27 is Rs. 1,500-1,800cr, along with an annual maintenance cost of approximately Rs. 200cr.

In light of the company's improved fundamentals, Geojit Financial Services has upgraded its rating on the stock to BUY, with a rolled-forward target price of Rs. 2,547, based on 26x FY28E adjusted Earnings Per Share (EPS).

Investor Takeaway

Investors should consider buying Balkrishna Industries with a target price of Rs 2547.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.